Treprostinil Sodium

CAS 81846-19-7 8 FDA-DMF suppliersSmall Molecule

Overview

Treprostinil Sodium is a stable salt form of treprostinil, a synthetic analogue of prostacyclin, which acts as a potent vasodilator. It is primarily used for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening.

API suppliers (2)

Suppliers of Treprostinil Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • EUROFINS CDMO ALPHORA INCCanada1 active DMF
  • EUROFINS CDMO ALPHORA INCCanada1 active DMF

Therapeutic areas

Cardiovascular DiseasesPulmonary Hypertension

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.